Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GRIGNON

Showing results (201-210 of 251) with videos related to

Pageof 26
Sort By:
The American Journal of Surgical Pathology|September 13, 2013
Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendationsKiril Trpkov, David J Grignon, Stephen M Bonsib, et al.
Histopathology|October 15, 2013
Cystic partially regressed clear cell renal cell carcinoma: a potential mimic of multilocular cystic renal cell carcinomaSean R Williamson, Gregory T MacLennan, Antonio Lopez-Beltran, et al.
Pathology, Research and Practice|September 1, 1995
Epidemiology of high grade prostatic intraepithelial neoplasiaW A Sakr, D J Grignon, G P Haas, et al.
The American Journal of Surgical Pathology|September 13, 2013
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parametersBrett Delahunt, John C Cheville, Guido Martignoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610A Pollack, D J Grignon, K H Heydon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 20, 2019
Recurrent KRAS mutations in papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, John N Eble, Mehdi Nassiri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2008
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancerEric M Horwitz, Kyounghwa Bae, Gerald E Hanks, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2016
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatmentEril J Kouba, John N Eble, Novae Simper, et al.
Cancer|February 26, 2004
Gene expression profiling of renal medullary carcinoma: potential clinical relevanceXiming J Yang, Jun Sugimura, Maria S Tretiakova, et al.
Urology|January 1, 1992
Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomyK I Wishnow, A K Levinson, D E Johnson, et al.
Pageof 26

Showing results (201-210 of 251) with videos related to

Sort By:
Pageof 26
The American Journal of Surgical Pathology|September 13, 2013
Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendationsKiril Trpkov, David J Grignon, Stephen M Bonsib, et al.
Histopathology|October 15, 2013
Cystic partially regressed clear cell renal cell carcinoma: a potential mimic of multilocular cystic renal cell carcinomaSean R Williamson, Gregory T MacLennan, Antonio Lopez-Beltran, et al.
Pathology, Research and Practice|September 1, 1995
Epidemiology of high grade prostatic intraepithelial neoplasiaW A Sakr, D J Grignon, G P Haas, et al.
The American Journal of Surgical Pathology|September 13, 2013
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parametersBrett Delahunt, John C Cheville, Guido Martignoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610A Pollack, D J Grignon, K H Heydon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 20, 2019
Recurrent KRAS mutations in papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, John N Eble, Mehdi Nassiri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2008
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancerEric M Horwitz, Kyounghwa Bae, Gerald E Hanks, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2016
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatmentEril J Kouba, John N Eble, Novae Simper, et al.
Cancer|February 26, 2004
Gene expression profiling of renal medullary carcinoma: potential clinical relevanceXiming J Yang, Jun Sugimura, Maria S Tretiakova, et al.
Urology|January 1, 1992
Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomyK I Wishnow, A K Levinson, D E Johnson, et al.
Pageof 26